Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

41. The comparative efficacy and safety of novel oral anticoagulants, warfarin and low molecular weight heparin in patients with cancer to prevent venous thromboembolism: a network meta-analysis

The comparative efficacy and safety of novel oral anticoagulants, warfarin and low molecular weight heparin in patients with cancer to prevent venous thromboembolism: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

42. The efficacy and safety of oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism (VTE) in hematologic malignancies: a systematic review and meta-analysis

The efficacy and safety of oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism (VTE) in hematologic malignancies: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

43. The interactions between anticonvulsants and novel oral anticoagulants in patients: a systematic review

The interactions between anticonvulsants and novel oral anticoagulants in patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

44. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer

Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

45. Direct oral anticoagulant use in chronic kidney disease and dialysis patients with venous thromboembolism: a systematic review of thrombosis and bleeding outcomes

Direct oral anticoagulant use in chronic kidney disease and dialysis patients with venous thromboembolism: a systematic review of thrombosis and bleeding outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

46. Continuous versus interrupted direct oral anticoagulation (DOAC) during cardiac implantable electronic device surgery: a systematic review and meta-analysis of randomized controlled trials

Continuous versus interrupted direct oral anticoagulation (DOAC) during cardiac implantable electronic device surgery: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

47. Comparing the efficacy and safety of the dual anti-thrombotic regimen with a single anti-platelet agent and newer oral anticoagulants versus the triple anti-thrombotic regimen with aspirin, clopidogrel and warfarin in patients with atrial fibrillation who

Comparing the efficacy and safety of the dual anti-thrombotic regimen with a single anti-platelet agent and newer oral anticoagulants versus the triple anti-thrombotic regimen with aspirin, clopidogrel and warfarin in patients with atrial fibrillation who Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

48. Uninterrupted non-vitamin K oral anticoagulants versus uninterrupted vitamin K antagonists for atrial fibrillation ablation: an updated meta-analysis of randomized and observational studies

Uninterrupted non-vitamin K oral anticoagulants versus uninterrupted vitamin K antagonists for atrial fibrillation ablation: an updated meta-analysis of randomized and observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

49. Thromboembolic outcomes of different anticoagulation strategies for patients with atrial fibrillation in the setting of hypertrophic cardiomyopathy: a systematic review and meta-analysis

Thromboembolic outcomes of different anticoagulation strategies for patients with atrial fibrillation in the setting of hypertrophic cardiomyopathy: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

50. Safety and efficacy of anticoagulant and antiplatelet combination treatment strategies in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: a network meta-analysis of randomized clinical trials

Safety and efficacy of anticoagulant and antiplatelet combination treatment strategies in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: a network meta-analysis of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

51. Comparing the risk of intracranial bleeding in seniors who fall on anticoagulation, antiplatelet medication or no antithrombotic medication

Comparing the risk of intracranial bleeding in seniors who fall on anticoagulation, antiplatelet medication or no antithrombotic medication Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

52. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis

Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

53. Direct oral anticoagulant (DOAC) versus placebo for the prevention of thrombosis in ambulatory patients with cancer at increased risk: a systematic review and meta-analysis

Direct oral anticoagulant (DOAC) versus placebo for the prevention of thrombosis in ambulatory patients with cancer at increased risk: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

54. Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with cancer and atrial fibrillation: a systematic review and meta-analysis

Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with cancer and atrial fibrillation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

55. Anti-platelets versus anticoagulants after left atrial occlusion devices: systematic review and meta-analysis

Anti-platelets versus anticoagulants after left atrial occlusion devices: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

56. Instruments for the assessment of patient adherence to oral anticoagulation with warfarin: systematic review

Instruments for the assessment of patient adherence to oral anticoagulation with warfarin: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

57. Factors influencing oral anticoagulant prescribing decisions for patients with atrial fibrillation: a systematic review of qualitative and quantitative evidence

Factors influencing oral anticoagulant prescribing decisions for patients with atrial fibrillation: a systematic review of qualitative and quantitative evidence Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

58. Assessment of sex-related quality of oral anticoagulation control: systematic review

Assessment of sex-related quality of oral anticoagulation control: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

59. Anticoagulant agents for preventing thromboembolic events in patients with atrial fibrillation and chronic kidney disease 3-5D stage: a systematic review

Anticoagulant agents for preventing thromboembolic events in patients with atrial fibrillation and chronic kidney disease 3-5D stage: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

60. Effectiveness of hemostatic protocols for prevention of bleeding in oral procedures in anticoagulated individuals. A systematic review and meta-analysis

Effectiveness of hemostatic protocols for prevention of bleeding in oral procedures in anticoagulated individuals. A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO